Base de dados : MEDLINE
Pesquisa : D23.050.301.290.501 [Categoria DeCS]
Referências encontradas : 325 [refinar]
Mostrando: 1 .. 10   no formato [Detalhado]

página 1 de 33 ir para página                         

  1 / 325 MEDLINE  
              next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28337749
[Au] Autor:Lee YH; Liao YJ; Huang CH; Chang FL; Fan TH; Twu YC
[Ad] Endereço:Department of Biotechnology and Laboratory Science in Medicine, National Yang-Ming University, Taipei, Taiwan.
[Ti] Título:Branched I antigens on leukemia cells enhanced sensitivity against natural killer-cell cytotoxicity through affecting the target-effector interaction.
[So] Source:Transfusion;57(4):1040-1051, 2017 Apr.
[Is] ISSN:1537-2995
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: The aberrant glycosylation on proteins and lipids has been implicated in malignant transformations for promoting the tumorigenesis, metastasis, and evasion from the host immunity. The I-branching ß-1,6-N-acetylglucosaminyltransferase, converting the straight i to branched I histo-blood group antigens, reportedly could influence the migration, invasion, and metastasis of solid tumors. STUDY DESIGN AND METHODS: We first chose the highly cytotoxic natural killer (NK)-92MI cells as effector against leukemia for this cell line has been used in several clinical trials. Fluorescence-activated cell sorting and nonradioactive cytotoxicity assay were performed to reexamine the role of NK-activating receptors, their corresponding ligands, and the tumor-associated carbohydrate antigens in this NK-92MI-leukemia in vitro system. The I role on cytotoxic mechanism was further studied especially on the effector-target interactions by cytotoxic analysis and conjugate formation assay. RESULTS: We showed that expression levels of leukemia surface ligands for NK-activating receptors did not positively reflect susceptibility to NK-92MI. Instead, the expression of I antigen on the leukemia cells was found important in mediating the susceptibility to NK targeting by affecting the interaction with effector cells. Furthermore, susceptibility was shown to dramatically increase while overexpressing branched I antigens on the I- cells. By both conjugate and cytotoxicity assay, we revealed that the presence of I antigen on leukemia cells enhanced the interaction with NK-92MI cells, increasing susceptibility to cell-mediated lysis. CONCLUSION: In our system, branched I antigens on the leukemia were involved in the immunosurveillance mediated by NK cells specifically through affecting the effector-target interaction.
[Mh] Termos MeSH primário: Antígenos de Neoplasias/imunologia
Sistema do Grupo Sanguíneo I/imunologia
Imunidade Celular
Células Matadoras Naturais/imunologia
Leucemia/imunologia
[Mh] Termos MeSH secundário: Linhagem Celular Tumoral
Seres Humanos
Células Matadoras Naturais/patologia
Leucemia/patologia
N-Acetilglucosaminiltransferases/imunologia
Proteínas de Neoplasias/imunologia
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Antigens, Neoplasm); 0 (I Blood-Group System); 0 (Neoplasm Proteins); EC 2.4.- (N-acetylglucosaminyltransferase IGnT); EC 2.4.1.- (N-Acetylglucosaminyltransferases)
[Em] Mês de entrada:1706
[Cu] Atualização por classe:170621
[Lr] Data última revisão:
170621
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170325
[St] Status:MEDLINE
[do] DOI:10.1111/trf.13982


  2 / 325 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:27600951
[Au] Autor:Liao YJ; Lee YH; Chang FL; Ho H; Huang CH; Twu YC
[Ad] Endereço:School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University.
[Ti] Título:The SHP2-ERK2 signaling pathway regulates branched I antigen formation by controlling the binding of CCAAT/enhancer binding protein α to the IGnTC promoter region during erythroid differentiation.
[So] Source:Transfusion;56(11):2691-2702, 2016 Nov.
[Is] ISSN:1537-2995
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: Phosphorylation status of the transcription factor CCAAT/enhancer binding protein α (C/EBPα) has been demonstrated in a human hematopoietic cell model to regulate the formation of branched I antigen by affecting its binding affinity to the promoter region of the IGnTC gene during erythroid and granulocytic differentiation. STUDY DESIGN AND METHODS: The K-562 cell line was induced to differentiate into red blood cells (RBCs) or granulocytes by sodium butyrate or retinoic acid, respectively, to study the involvement of three MAP kinase pathways in I antigen synthesis. The regulatory effects of the extracellular signal-regulated kinase (ERK)2-Src homology region 2 domain-containing phosphatase 2 (SHP2) pathway on phosphorylation status and binding affinities of C/EBPα as well as the subsequent activation of IGnTC and synthesis of surface I formation were studied in wild-type K-562 cells and in mutant cells that overexpress ERK2 and SHP2. RESULTS: We found that SHP2-ERK2 signaling regulates the phosphorylation status of C/EBPα to alter its binding affinity onto the IGnTC promoter region, thereby activating the synthesis of cell surface I antigen formation during erythropoiesis. CONCLUSION: SHP2-ERK2 signaling acts upstream of C/EBPα as a regulator of cell surface I antigen synthesis. Such regulation is specific for RBC but not for granulocyte differentiation.
[Mh] Termos MeSH primário: Proteína alfa Estimuladora de Ligação a CCAAT/metabolismo
Eritropoese
Sistema do Grupo Sanguíneo I/biossíntese
Proteína Quinase 1 Ativada por Mitógeno/metabolismo
N-Acetilglucosaminiltransferases/metabolismo
Proteína Tirosina Fosfatase não Receptora Tipo 11/metabolismo
Transdução de Sinais
[Mh] Termos MeSH secundário: Seres Humanos
Células K562
N-Acetilglucosaminiltransferases/genética
N-Acetilexosaminiltransferases
Fosforilação
Regiões Promotoras Genéticas
Ligação Proteica
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (CCAAT-Enhancer-Binding Protein-alpha); 0 (I Blood-Group System); EC 2.4.- (N-acetylglucosaminyltransferase IGnT); EC 2.4.1.- (GCNT2 protein, human); EC 2.4.1.- (N-Acetylglucosaminyltransferases); EC 2.4.1.- (N-Acetylhexosaminyltransferases); EC 2.7.11.24 (MAPK1 protein, human); EC 2.7.11.24 (Mitogen-Activated Protein Kinase 1); EC 3.1.3.48 (Protein Tyrosine Phosphatase, Non-Receptor Type 11)
[Em] Mês de entrada:1705
[Cu] Atualização por classe:170525
[Lr] Data última revisão:
170525
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:160908
[St] Status:MEDLINE
[do] DOI:10.1111/trf.13796


  3 / 325 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
[PMID]:25238244
[Au] Autor:Joshi SR
[Ad] Endereço:PhD, Associate Professor, Allianze University College of Medical Sciences, Waziria Medical Square, Jalan Bertam 2, Mukim 6, Kepala Batas 13200, Penang, Malaysia.
[Ti] Título:I-int phenotype among three individuals of a Parsi community from Mumbai, India.
[So] Source:Immunohematology;30(1):11-3, 2014.
[Is] ISSN:0894-203X
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:The red blood cells (RBCs) of most adult individuals display an I+i- phenotype, whereas those of newborns and some rare adult individuals are typed as I-i+. The phenotype in the latter category, designated as adult i, is under genetic influence as the RBCs of I+i+ individuals display strengths of I and i antigen expression intermediate to that of ordinary adults and ii-adults. As there was no information on the occurrence of adult i phenotype in the Indian population, the present study was undertaken. The RBCs of randomly selected subjects were screened with anti-I and anti-i reagents by a saline tube technique at 220C. Individuals with unusual I and i antigen reactivity patterns were further tested by a semi-quantitative method with a battery of anti-I and anti-i reagents, followed by family studies. Three of the 5864 donors tested showed an elevated strength of i antigen. Further study revealed an intermediate strength of both I and i antigens compared with those on RBCs from adult and cord blood samples. All three probands came from an ethnic Parsi community. The phenotype (referred to as I-int) was shown to be inherited, being passed through two generations, but none of the members of the families had displayed an adult i phenotype. The I-int phenotype detected showed an ethnic association because all three subjects belonged to an endogamous Parsi community that has migrated to India some centuries ago from Persia, the present-day Iran.
[Mh] Termos MeSH primário: Sistema do Grupo Sanguíneo I/análise
[Mh] Termos MeSH secundário: Eritrócitos/química
Grupos Étnicos
Feminino
Seres Humanos
Sistema do Grupo Sanguíneo I/genética
Índia
Masculino
Linhagem
Fenótipo
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Nm] Nome de substância:
0 (I Blood-Group System)
[Em] Mês de entrada:1410
[Cu] Atualização por classe:161021
[Lr] Data última revisão:
161021
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:140920
[St] Status:MEDLINE


  4 / 325 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:22763946
[Au] Autor:Hubeek I; ter Heide H; van Solinge WW; de Vooght KM
[Ti] Título:Hypothermic cardiopulmonary bypass surgery in a 7-year-old boy with a cold agglutinin.
[So] Source:Ann Hematol;91(12):1989-90, 2012 Dec.
[Is] ISSN:1432-0584
[Cp] País de publicação:Germany
[La] Idioma:eng
[Mh] Termos MeSH primário: Ponte Cardiopulmonar
Hipotermia Induzida
Complicações Intraoperatórias/prevenção & controle
[Mh] Termos MeSH secundário: Ponte Cardiopulmonar/efeitos adversos
Criança
Temperatura Baixa/efeitos adversos
Crioglobulinas/análise
Procedimentos Cirúrgicos Eletivos
Seres Humanos
Hipotermia Induzida/efeitos adversos
Sistema do Grupo Sanguíneo I/química
Masculino
Cuidados Pré-Operatórios
Testes Sorológicos
Fatores de Tempo
Resultado do Tratamento
[Pt] Tipo de publicação:CASE REPORTS; LETTER
[Nm] Nome de substância:
0 (Cryoglobulins); 0 (I Blood-Group System); 0 (cold agglutinins)
[Em] Mês de entrada:1301
[Cu] Atualização por classe:141120
[Lr] Data última revisão:
141120
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:120706
[St] Status:MEDLINE
[do] DOI:10.1007/s00277-012-1515-1


  5 / 325 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:21933024
[Au] Autor:Hirvonen T; Suila H; Kotovuori A; Ritamo I; Heiskanen A; Sistonen P; Anderson H; Satomaa T; Saarinen J; Tiitinen S; Räbinä J; Laitinen S; Natunen S; Valmu L
[Ad] Endereço:Department of Advanced Therapy and Product Development, Finnish Red Cross Blood Service, Helsinki, Finland.
[Ti] Título:The i blood group antigen as a marker for umbilical cord blood-derived mesenchymal stem cells.
[So] Source:Stem Cells Dev;21(3):455-64, 2012 Feb 10.
[Is] ISSN:1557-8534
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Multipotent mesenchymal stem cells (MSCs) offer great promise for future regenerative and anti-inflammatory therapies. However, there is a lack of methods to quickly and efficiently isolate, characterize, and ex vivo expand desired cell populations for therapeutic purposes. Single markers to identify cell populations have not been characterized; instead, all characterizations rely on panels of functional and phenotypical properties. Glycan epitopes can be used for identifying and isolating specific cell types from heterogeneous populations, on the basis of their cell-type specific expression and prominent cell surface localization. We have now studied in detail the cell surface expression of the blood group i epitope (linear poly-N-acetyllactosamine chain) in umbilical cord blood (UCB)-derived MSCs. We used flow cytometry and mass spectrometric glycan analysis and discovered that linear poly-N-acetyllactosamine structures are expressed in UCB-derived MSCs, but not in cells differentiated from them. We further verified the findings by mass spectrometric glycan analysis. Gene expression analysis indicated that the stem-cell specific expression of the i antigen is determined by ß3-N-acetylglucosaminyltransferase 5. The i antigen is a ligand for the galectin family of soluble lectins. We found concomitant cell surface expression of galectin-3, which has been reported to mediate the immunosuppressive effects exerted by MSCs. The i antigen may serve as an endogenous ligand for this immunosuppressive agent in the MSC microenvironment. Based on these findings, we suggest that linear poly-N-acetyllactosamine could be used as a novel UCB-MSC marker either alone or within an array of MSC markers.
[Mh] Termos MeSH primário: Sangue Fetal/citologia
Galectina 3/metabolismo
Sistema do Grupo Sanguíneo I/metabolismo
Células Mesenquimais Estromais/citologia
[Mh] Termos MeSH secundário: Amino Açúcares/metabolismo
Biomarcadores/análise
Diferenciação Celular
Epitopos/química
Sangue Fetal/metabolismo
Citometria de Fluxo
Galectina 3/genética
Perfilação da Expressão Gênica
Seres Humanos
Ligantes
Espectrometria de Massas
Células Mesenquimais Estromais/metabolismo
N-Acetilglucosaminiltransferases/genética
Nicho de Células-Tronco
[Pt] Tipo de publicação:JOURNAL ARTICLE; RESEARCH SUPPORT, NON-U.S. GOV'T
[Nm] Nome de substância:
0 (Amino Sugars); 0 (Biomarkers); 0 (Epitopes); 0 (Galectin 3); 0 (I Blood-Group System); 0 (Ligands); 3Y5B2K5OOK (N-acetyllactosamine); EC 2.4.1.- (N-Acetylglucosaminyltransferases)
[Em] Mês de entrada:1205
[Cu] Atualização por classe:151119
[Lr] Data última revisão:
151119
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:110922
[St] Status:MEDLINE
[do] DOI:10.1089/scd.2011.0405


  6 / 325 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
[PMID]:22356549
[Au] Autor:Win N; Needs M; Rahman S; Gold P; Ward S
[Ad] Endereço:Red Cell Immunohaematology, NHSBT-Tooting Centre, 75, Cranmer Terrace, Tooting, United Kingdom SW17 0RB.
[Ti] Título:An unusual case of an acute hemolytic transfusion reaction caused by an autoanti-I.
[So] Source:Immunohematology;27(3):101-3, 2011.
[Is] ISSN:1930-3955
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:In general, naturally occurring cold autoagglutinins react optimally at low temperatures. We describe a young child who experienced an acute hemolytic transfusion reaction by an unusual autoanti-I. The IgM autoanti-I was detected at 4°C (titer 256) and also reacted at 30°C. This case highlights the potential hazard of transfusing units of blood immediately upon removal from the blood refrigerator, especially into neonates and children of small stature.
[Mh] Termos MeSH primário: Anemia Hemolítica Autoimune/sangue
Anemia Hemolítica Autoimune/imunologia
Autoanticorpos/sangue
Incompatibilidade de Grupos Sanguíneos/sangue
Temperatura Baixa/efeitos adversos
Sistema do Grupo Sanguíneo I/imunologia
[Mh] Termos MeSH secundário: Doença Aguda
Autoanticorpos/efeitos adversos
Incompatibilidade de Grupos Sanguíneos/complicações
Tipagem e Reações Cruzadas Sanguíneas
Células Cultivadas
Criança
Reações Falso-Positivas
Guias como Assunto
Seres Humanos
Masculino
Ligação Proteica
Reprodutibilidade dos Testes
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Autoantibodies); 0 (I Blood-Group System)
[Em] Mês de entrada:1208
[Cu] Atualização por classe:161021
[Lr] Data última revisão:
161021
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:120224
[St] Status:MEDLINE


  7 / 325 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:21912254
[Au] Autor:Yu LC; Lin M
[Ad] Endereço:Institute of Biochemical Sciences, College of Life Science, National Taiwan University, Taipei, Taiwan. yulc@ntu.edu.tw
[Ti] Título:Molecular genetics of the blood group I system and the regulation of I antigen expression during erythropoiesis and granulopoiesis.
[So] Source:Curr Opin Hematol;18(6):421-6, 2011 Nov.
[Is] ISSN:1531-7048
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:PURPOSE OF REVIEW: The molecular genetics of the blood group I system and the regulation mechanism for I antigen expression in postnatal red blood cells are intriguing. This review summarizes their elucidation and recent findings. RECENT FINDINGS: Accumulating data from the molecular analysis of individuals with the adult i phenotype supports the proposed molecular genetic mechanism for the partial association of the adult i phenotype with congenital cataracts. Recent investigations have shown that the regulation of I antigen formation during erythropoiesis is determined by transcription factor CCAAT/enhancer binding protein-α (C/EBPα) and the phosphorylation status of C/EBPα Ser-21 residue. SUMMARY: The human I locus is organized such that it has an uncommon genetic architecture and expresses three different I transcript forms. The results obtained from molecular analysis of two adult i groups, with and without congenital cataracts, demonstrate that the molecular background accounts for the partial association between these two traits and suggest that an I gene defect may lead directly to the development of congenital cataracts. Analysis of the regulation for I antigen expression shows that the regulation during erythropoiesis and granulopoiesis share a common mechanism, with dephosphorylation of the Ser-21 residue on C/EBPα playing the critical role.
[Mh] Termos MeSH primário: Eritropoese/fisiologia
Glicoesfingolipídeos/metabolismo
Sistema do Grupo Sanguíneo I/genética
Sistema do Grupo Sanguíneo I/imunologia
Leucopoese/fisiologia
[Mh] Termos MeSH secundário: Catarata/congênito
Catarata/imunologia
Eritrócitos/metabolismo
Eritropoese/genética
Seres Humanos
Leucopoese/genética
[Pt] Tipo de publicação:JOURNAL ARTICLE; RESEARCH SUPPORT, NON-U.S. GOV'T; REVIEW
[Nm] Nome de substância:
0 (Glycosphingolipids); 0 (I Blood-Group System); 0 (I-antigen)
[Em] Mês de entrada:1201
[Cu] Atualização por classe:111012
[Lr] Data última revisão:
111012
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:110914
[St] Status:MEDLINE
[do] DOI:10.1097/MOH.0b013e32834baae9


  8 / 325 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:21658050
[Au] Autor:Irani MS; Richards C
[Ad] Endereço:Tricore Reference Laboratories at Presbyterian Hospital Blood Bank, Albuquerque, New Mexico, USA. mirani@bloodsystems.org
[Ti] Título:Hemolytic transfusion reaction due to anti-IH.
[So] Source:Transfusion;51(12):2676-8, 2011 Dec.
[Is] ISSN:1537-2995
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: Anti-IH is usually a clinically insignificant antibody that may complicate a serologic workup. However, it can occasionally cause hemolysis. We report a rare case of acute hemolysis caused by anti-IH. CASE REPORT: A 60-year-old man with a long history of chronic myelomonocytic leukemia and anemia, blood group A, D+ was found to have an unidentified antibody on serologic workup. He received an A, D+ red blood cell (RBC) unit that was crossmatch compatible by immunoglobulin G indirect antiglobulin test and then experienced an acute hemolytic transfusion reaction with fever, hemoglobinuria, and acute renal failure. The antibody was later identified as an anti-IH with a wide thermal amplitude. The transfused RBCs were later typed as A(2). The patient was subsequently typed as an A(1) individual. The patient recovered completely from the effects of this reaction and was transfused with A(1) RBCs over the next few days with no adverse effect. CONCLUSION: Anti-IH, which is usually clinically insignificant and often found in A(1), B, and A(1) B individuals, can, on rare occasions, cause acute hemolytic transfusion reactions, especially when an A(2) unit is transfused to an A(1) patient.
[Mh] Termos MeSH primário: Incompatibilidade de Grupos Sanguíneos/sangue
Transfusão de Eritrócitos/efeitos adversos
Hemólise
Sistema do Grupo Sanguíneo I
Isoanticorpos/sangue
[Mh] Termos MeSH secundário: Sistema do Grupo Sanguíneo ABO/sangue
Lesão Renal Aguda/sangue
Lesão Renal Aguda/etiologia
Idoso
Anemia/sangue
Anemia/terapia
Incompatibilidade de Grupos Sanguíneos/etiologia
Tipagem e Reações Cruzadas Sanguíneas
Hemoglobinúria/sangue
Hemoglobinúria/etiologia
Seres Humanos
Leucemia Mielogênica Crônica BCR-ABL Positiva/sangue
Leucemia Mielogênica Crônica BCR-ABL Positiva/terapia
Masculino
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Nm] Nome de substância:
0 (ABO Blood-Group System); 0 (I Blood-Group System); 0 (Isoantibodies)
[Em] Mês de entrada:1202
[Cu] Atualização por classe:111214
[Lr] Data última revisão:
111214
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:110611
[St] Status:MEDLINE
[do] DOI:10.1111/j.1537-2995.2011.03209.x


  9 / 325 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
[PMID]:22356451
[Au] Autor:Cooling L
[Ad] Endereço:University of Michigan Hospitals, Ann Arbor, MI 48109-0054, USA.
[Ti] Título:Polylactosamines, there's more than meets the "Ii": a review of the I system.
[So] Source:Immunohematology;26(4):133-55, 2010.
[Is] ISSN:1930-3955
[Cp] País de publicação:United States
[La] Idioma:eng
[Mh] Termos MeSH primário: Amino Açúcares/sangue
Eritrócitos Anormais/metabolismo
Eritropoese
Doenças Hematológicas/sangue
Sistema do Grupo Sanguíneo I/sangue
Polissacarídeos/sangue
[Mh] Termos MeSH secundário: Amino Açúcares/biossíntese
Amino Açúcares/química
Amino Açúcares/genética
Animais
Anticorpos/metabolismo
Sequência de Carboidratos
Eritrócitos Anormais/patologia
Regulação da Expressão Gênica no Desenvolvimento
Predisposição Genética para Doença
Seres Humanos
Sistema do Grupo Sanguíneo I/biossíntese
Sistema do Grupo Sanguíneo I/química
Sistema do Grupo Sanguíneo I/genética
Dados de Sequência Molecular
Polimorfismo Genético
Polissacarídeos/biossíntese
Polissacarídeos/química
Polissacarídeos/genética
Transporte Proteico
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Nm] Nome de substância:
0 (Amino Sugars); 0 (Antibodies); 0 (I Blood-Group System); 0 (Polysaccharides); 100787-31-3 (polylactosamine)
[Em] Mês de entrada:1207
[Cu] Atualização por classe:161021
[Lr] Data última revisão:
161021
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:120224
[St] Status:MEDLINE


  10 / 325 MEDLINE  
              first record previous record
seleciona
para imprimir
Fotocópia
[PMID]:20942187
[Au] Autor:Endoh T; Watanabe N
[Ad] Endereço:Division of Laboratory Diagnosis, Sapporo Medical University Hospital.
[Ti] Título:[Ii blood group system].
[So] Source:Nihon Rinsho;68 Suppl 6:777-9, 2010 Jun.
[Is] ISSN:0047-1852
[Cp] País de publicação:Japan
[La] Idioma:jpn
[Mh] Termos MeSH primário: Anticorpos/sangue
Transfusão de Sangue
Sistema do Grupo Sanguíneo I/imunologia
[Mh] Termos MeSH secundário: Tipagem e Reações Cruzadas Sanguíneas
Doenças Hematológicas/sangue
Seres Humanos
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Antibodies); 0 (I Blood-Group System)
[Em] Mês de entrada:1012
[Cu] Atualização por classe:110727
[Lr] Data última revisão:
110727
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:101015
[St] Status:MEDLINE



página 1 de 33 ir para página                         
   


Refinar a pesquisa
  Base de dados : MEDLINE Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde